56
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
631396
New Amsterdam Sciences (NAS) is a clinical-stage bioscience company,
- Michael Wilhelm: President & CEO
About the Company
New Amsterdam Sciences (NAS) is a clinical-stage bioscience company focused on the research, development and licensing of small molecule antioxidant SOD mimetics and peptide analogues of Substance P. The company’s lead compound, NAS150, is being pursued for indications including Progressive Supranuclear Palsy, Idiopathic Pulmonary Fibrosis, and
Radiation-Induced Lung Injury. New Amsterdam Sciences is devoted to developing products with not only commercial value but having governmental appeal, with a focus on mass casualty biodefense applications.
